Ondansetron 4mg/2mL Injection

Ondansetron 4mg/2mL Injection is an antiemetic used to prevent or treat nausea and vomiting related to surgery, chemotherapy, radiotherapy, gastroenteritis, or other clinician-assessed causes. It blocks 5-HT3 serotonin receptors involved in nausea signaling between the gut and brain. Oral-disintegrating forms are useful when swallowing is difficult, while injections are used in supervised settings.
Use Ondansetron 4mg/2mL Injection as prescribed for the nausea trigger. Use OD tablets according to the dissolving directions. Injection strengths are for healthcare-professional administration.
Ondansetron blocks 5-HT3 receptors in the gut and central nervous system, reducing nausea and vomiting signals.
Ondansetron may cause headache or constipation; dizziness, flushing, and tiredness can also occur. Important risks include QT prolongation, rhythm changes, serotonin syndrome, severe allergic reaction, and delayed recognition of bowel obstruction.
Key checks include heart-rhythm history, electrolyte problems, liver disease, bowel-obstruction symptoms, pregnancy or breastfeeding, tramadol, SSRIs/SNRIs, serotonergic therapy, and QT-prolonging medicines.
Nausea and vomiting prevention or treatment when ondansetron is prescribed.
Can control vomiting and support hydration or treatment completion when matched to the cause.
Ondansetron may be prescribed to prevent or treat nausea and vomiting from suitable triggers.
Use Ondansetron 4mg/2mL Injection as prescribed for the nausea trigger. Use OD tablets according to the dissolving directions. Injection strengths are for healthcare-professional administration.
Your doctor may check heart-rhythm history, electrolyte problems, liver disease, bowel-obstruction symptoms, pregnancy or breastfeeding, tramadol, SSRIs/SNRIs, serotonergic therapy, and QT-prolonging medicines.
Ondansetron may cause headache or constipation; dizziness, flushing, and tiredness can also occur. Important risks include QT prolongation, rhythm changes, serotonin syndrome, severe allergic reaction, and delayed recognition of bowel obstruction.
Ondansetron, Antiemetic medicine, 5-HT3 receptor antagonist, Chemotherapy nausea, QT prolongation warning, AR: Ondansetron / حقن, FR: Ondansetron /, PT: Ondansetron / injeção, ES: Ondansetron / inyección, RU: Ondansetron / инъекция, ID: Ondansetron / injeksi, VI: Ondansetron / thuốc tiêm, MS: Ondansetron / suntikan, TL: Ondansetron / iniksyon, ZH-SG: Ondansetron / 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Ondansetron 4mg/2mL Injection under Digestive Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Ondansetron 4mg/2mL Injection